Iovance Biotherapeutics (NASDAQ:IOVA) is preparing to release its quarterly earnings on Tuesday, 2026-02-24. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect Iovance Biotherapeutics to report an earnings per share (EPS) of $-0.19.
The announcement from Iovance Biotherapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It’s worth noting for new investors that guidance can be a key determinant of stock price movements.
Overview of Past Earnings
In the previous earnings release, the company beat EPS by $0.02, leading to a 0.43% drop in the share price the following trading session.
Here’s …